5[4]Connolly ES,winfree CJ,prestigiacomo CJ,et al.Exacerbation of cerebral injury in mice that express the P-selectin gene:indentification of P-selectin blockade as a new target for the treatment of stroke[J].Cire Res,1997,81(3):304～310
6[5]Zhang RL,Chopp M,Zhang ZG,et al.The espression of P-and E-selectins in three models cerebral artery occulation[J].BrainRes,1998,785(2):107～214
7Abe, K. et al. Strong attenuation of ischemic and postischemic brain edema in rats by a novel freeradical scavenger.Srroke, 19:480-485,1988.
8Kharasch , E D and Novak, R F. Mitoxantrone and ametantrone inhibit hydroperoxide-dependent initiation and propagation reactions in fatty acid peroxldationd. J Biol Chem,260:10645-10652,1985.
9Abe, K et al.:Strong attenuation of ischemic and postischemic brain edema in rats by a novel freeradical scavenger.Srroke, 19:480-485,1988.?A
10Kharasch, E D and Novak, R F : Mitoxantrone and ametantrone inhibit hydroperoxide-dependent initiation and propagation reactions in fatty acid peroxidation.J. Biol, Ghem,260:10645-10652,1985.?A
7Felberg RA, Burgin WS, Grotta JC. Neurop rotection and the is- chemic cascade. C-NS Spectrums, 2005, 10(5): 52-58.
8Tanaka M. Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent. Nippon Yakurigaku Zasshi, 2002, 119(5): 301-308.
9Takabatake Y, Uno E, Wakamatsu K, et al. The clinical effect of combination therapy with edaravone and sodi- urn ozagrel for acute cerebral infarction. No To Shinkei, 2003, 55(7): 589-593.
10Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of re- ports of randomized clinical trials: is blinding necessary. Control Clin Trials, 1996, 17(1): 1-12.
